Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 4, 2010, Pages 742-749

  Akutsu, Yasushi ^a   Kaneko, Kyouichi ^a   Kodama, Yusuke ^a   Li, Hui Ling ^a   Suyama, Jumpei ^a   Shinozuka, Akira ^a   Gokan, Takehiko ^a   Kawamura, Mitsuharu ^a   Asano, Taku ^a   Hamazaki, Yuji ^a   Tanno, Kaoru ^a   Kobayashi, Youichi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; C reactive protein; Sympathetic nervous system; Vascular events

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; C REACTIVE PROTEIN;

ADRENERGIC SYSTEM; AGE DETERMINATION; AGED; ARTICLE; BRAIN FUNCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; SINUS RHYTHM; STROKE; VASCULAR DISEASE;

3-IODOBENZYLGUANIDINE; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; IODINE RADIOISOTOPES; JAPAN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK; STROKE; SYMPATHETIC NERVOUS SYSTEM;

EID: 77952097355     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1322-7     Document Type: Article

References (49)

1. V Fuster LE Rydén DS Cannom HJ Crijns AB Curtis KA Ellenbogen, et al. 2006 ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 e257 e354 10.1161/CIRCULATIONAHA.106.177292 16908781 (Pubitemid 44252297)
2. S Stewart CL Hart DJ Hole JJ McMurray 2002 A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study Am J Med 113 359 364 10.1016/S0002-9343(02)01236-6 12401529 (Pubitemid 35223606)
3. RG Hart LA Pearce R McBride RM Rothbart RW Asinger 1999 Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators Stroke 30 1223 1229 1:STN:280:DyaK1M3osVOguw%3D%3D 10356104
4. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med 1998;158:1316-20. (Pubitemid 28287524)
5. A Jahangir V Lee PA Friedman JM Trusty DO Hodge SL Kopecky, et al. 2007 Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study Circulation 115 3050 3056 10.1161/CIRCULATIONAHA.106.644484 17548732 (Pubitemid 46956493)
6. SL Kopecky 1999 Idiopathic atrial fibrillation: prevalence, course, treatment, and prognosis J Thromb Thrombolysis 7 27 31 10.1023/A:1008871118641 1:STN:280:DyaK1M3mvFKmsw%3D%3D 10337357 (Pubitemid 29090118)
7. L Frost 2007 Lone atrial fibrillation: good, bad, or ugly? Circulation 115 3040 3041 10.1161/CIRCULATIONAHA.107.709287 17576879 (Pubitemid 46956489)
8. Camm AJ, Savelieva I, Bharati SJ, Lindsay BD, Nattel S, Shinagawa K, et al. Atrial tachycardia, flutter, and fibrillation. In: Saksena S, Camm AJ, Boyden PA, Dorian P, Goldschlager N, editors. Electrophysiological disorders of the heart. Philadelphia: Elsevier Health Sciences, Churchill Livingstone; 2005. p. 283-363.
9. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fbrillation. Eur Heart J 2009;doi: 10.1093/eurheart/ehn599.
10. R Nieuwlaat T Dinh SB Olsson AJ Camm A Capucci RG Tieleman, et al. 2008 Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J 29 915 922 10.1093/eurheartj/ehn101 18334476 (Pubitemid 351499500)
11. KW Mahaffey CB Granger MA Sloan TD Thompson JM Gore WD Weaver, et al. 1998 Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I Circulation 97 757 764 1:STN:280:DyaK1c7lvVejtg%3D%3D 9498539 (Pubitemid 28135338)
12. GY Lip JV Patel E Hughes RG Hart 2007 High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis Stroke 38 1229 1237 10.1161/01.STR.0000260090.90508.3e 1:CAS:528:DC%2BD2sXjtFynsbw%3D 17332453 (Pubitemid 351664238)
13. Y Akutsu K Kaneko Y Kodama HL Li M Kawamura T Asano, et al. 2008 Cardiac sympathetic nerve abnormality predicts ventricular tachyarrhythmic events in patients without conventional risk of sudden death Eur J Nucl Med Mol Imaging 35 2066 2073 10.1007/s00259-008-0879-x 18622611
14. Y Akutsu K Kaneko Y Kodama HL Li M Kawamura T Asano, et al. 2009 The significance of cardiac sympathetic nervous system abnormality in the long-term prognosis of patients with a history of ventricular tachyarrhythmia J Nucl Med 50 61 67 10.2967/jnumed.108.055194 19091900
15. M Osranek F Bursi KR Bailey BR Grossardt RD Brown SL Kopecky, et al. 2005 Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up Eur Heart J 26 2556 2561 10.1093/eurheartj/ehi483 16141257 (Pubitemid 41679360)
16. E Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Soc 53 457 481
17. D Cox 1972 Regression models and life tables J R Stat Soc B 34 187 220
18. C Zoccali F Mallamaci S Parlongo S Cutrupi FA Benedetto G Tripepi, et al. 2002 Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease Circulation 105 1354 1359 10.1161/hc1102.105261 1:CAS:528:DC%2BD38XjtFalsL8%3D 11901048 (Pubitemid 34260428)
19. T Wakabayashi T Nakata A Hashimoto S Yuda K Tsuchihashi MI Travin, et al. 2001 Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death J Nucl Med 42 1757 1767 1:STN:280:DC%2BD38%2FgtlOhtg%3D%3D 11752070 (Pubitemid 34016342)
20. P Merlet C Benvenuti D Moyse F Pouillart JL Dubois-Randé AM Duval, et al. 1999 Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy J Nucl Med 40 917 923 1:STN:280:DyaK1MznvFektw%3D%3D 10452306 (Pubitemid 29269210)
21. M Mabuchi M Imamura N Kubo K Morita K Noriyasu T Tsukamoto, et al. 2005 Sympathetic denervation and reinnervation after the maze procedure J Nucl Med 46 1089 1094 16000276 (Pubitemid 43741069)
22. D Nagahara T Nakata A Hashimoto T Wakabayashi M Kyuma R Noda, et al. 2008 Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function J Nucl Med 49 225 233 10.2967/jnumed.107.042564 18199625 (Pubitemid 351225660)
23. G Mancia G Grassi C Giannattasio G Seravalle 1999 Sympathetic activation in the pathogenesis of hypertension and progression of organic damage Hypertension 34 724 728 1:STN:280:DyaK1Mvlt1ygsQ%3D%3D 10523349 (Pubitemid 29501288)
24. P Chen AY Tan 2007 Autonomic nerve activity and atrial fibrillation Heart Rhythm 4 S61 S64 10.1016/j.hrthm.2006.12.006 17336887 (Pubitemid 46335614)
25. S Kasama T Toyama H Kumakura Y Takayama S Ichikawa T Suzuki, et al. 2005 Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction J Am Coll Cardiol 45 661 667 10.1016/j.jacc.2004.11.038 1:CAS:528: DC%2BD2MXhslegsL0%3D 15734608 (Pubitemid 40278963)
26. S Tamaki T Yamada Y Okuyama T Morita S Sanada Y Tsukamoto, et al. 2009 Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion J Am Coll Cardiol 53 426 435 10.1016/j.jacc.2008. 10.025 1:CAS:528:DC%2BD1MXhtlShsbc%3D 19179201
27. U Lotze A Kober S Kaepplinger S Neubauer D Gottschild HR Figulla 1999 Cardiac sympathetic activity as measured by myocardial 123-I- metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy Am J Cardiol 83 1548 1551 10.1016/S0002-9149(99)00145-9 1:STN:280:DyaK1M3ptVGgtQ%3D%3D 10363869 (Pubitemid 29250038)
28. P Korantzopoulos TM Kolettis D Galaris JA Goudevenos 2007 The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation Int J Cardiol 115 135 143 10.1016/j.ijcard.2006.04.026 16764958 (Pubitemid 46136515)
29. MC Wijffels CJ Kirchhof R Dorland MA Allessie 1995 Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1954 1968 1:STN:280:DyaK2MvgtFemtg%3D%3D 7671380
30. H Sohara S Amitani M Kurose K Miyahara 1997 Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation J Am Coll Cardiol 29 106 112 10.1016/S0735- 1097(96)00427-5 1:STN:280:DyaK2s7kvFCqtg%3D%3D 8996302 (Pubitemid 27028727)
31. RJ Aviles DO Martin C Apperson-Hansen PL Houghtaling P Rautaharju RA Kronmal, et al. 2003 Inflammation as a risk factor for atrial fibrillation Circulation 108 3006 3010 10.1161/01.CIR.0000103131.70301.4F 14623805 (Pubitemid 37553570)
32. PM Ridker CP Cannon D Morrow N Rifai LM Rose CH McCabe, et al. 2005 C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 20 28 10.1056/NEJMoa042378 1:CAS:528:DC%2BD2MXis12msA%3D%3D 15635109 (Pubitemid 40075677)
33. M Schillinger M Exner J Amighi W Mlekusch S Sabeti H Rumpold, et al. 2003 Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis Circulation 108 2323 2328 10.1161/01.CIR.0000095267.24234.00 1:CAS:528:DC%2BD3sXos1Smsr4%3D 14557362 (Pubitemid 37413537)
34. I Ikonomidis J Lekakis I Revela F Andreotti P Nihoyannopoulos 2005 Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease Eur Heart J 26 1618 1624 10.1093/eurheartj/ ehi192 1:CAS:528:DC%2BD2MXhtVensLjI 15800017 (Pubitemid 41389692)
35. X Jouven JP Empana PJ Schwartz M Desnos D Courbon P Ducimetière 2005 Heart-rate profile during exercise as a predictor of sudden death N Engl J Med 352 1951 1958 10.1056/NEJMoa043012 1:CAS:528:DC%2BD2MXjvFyrtrc%3D 15888695 (Pubitemid 40638365)
36. A Sajadieh OW Nielsen V Rasmussen HO Hein S Abedini JF Hansen 2004 Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease Eur Heart J 25 363 370 10.1016/j.ehj.2003.12.003 15033247 (Pubitemid 38391517)
37. GF Diakakis FI Parthenakis AP Patrianakos SI Koukouraki MI Stathaki NS Karkavitsas, et al. 2008 Myocardial sympathetic innervation in patients with impaired glucose tolerance: relationship to subclinical inflammation Cardiovasc Pathol 17 172 177 10.1016/j.carpath.2007.07.007 1:CAS:528:DC%2BD1cXlslOqt7c%3D 18402797 (Pubitemid 351615291)
38. GJ Maestroni M Cosentino F Marino M Togni A Conti S Lecchini, et al. 1998 Neural and endogenous catecholamines in the bone marrow. Circadian association of norepinephrine with hematopoiesis? Exp Hematol 26 1172 1177 1:CAS:528:DyaK1cXnsVOgsr4%3D 9808057 (Pubitemid 28507293)
39. GJ Maestroni A Conti 1994 Noradrenergic modulation of lymphohematopoiesis Int J Immunopharmacol 16 117 122 10.1016/0192-0561(94)90067-1 1:CAS:528:DyaK2cXitFGhsbk%3D 8181900 (Pubitemid 24063514)
40. R von Kanel JE Dimsdale KA Adler E Dillon CJ Perez PJ Mills 2003 Effects of nonspecific beta-adrenergic stimulation and blockade on blood coagulation in hypertension J Appl Physiol 94 1455 1459 (Pubitemid 36348822)
41. R von Känel JE Dimsdale 2000 Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo Eur J Haematol 65 357 369 10.1034/j.1600-0609.2000.065006357.x
42. P Panina-Bordignon D Mazzeo PD Lucia D D'Ambrosio R Lang L Fabbri, et al. 1997 Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12 J Clin Invest 100 1513 1519 10.1172/JCI119674 1:CAS:528:DyaK2sXmt1Cqsbk%3D 9294119 (Pubitemid 27425778)
43. IJ Elenkov RL Wilder GP Chrousos ES Vizi 2000 The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system Pharmacol Rev 52 595 638 1:CAS:528:DC%2BD3MXislWksQ%3D%3D 11121511
44. MJ Mihm F Yu CA Carnes PJ Reiser PM McCarthy DR Van Wagoner, et al. 2001 Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 174 180 1:CAS:528:DC%2BD3MXlvVKktbY%3D 11447082 (Pubitemid 32655834)
45. M Acevedo R Corbalán S Braun J Pereira C Navarrete I Gonzalez 2006 C-reactive protein and atrial fibrillation: "evidence for the presence of inflammation in the perpetuation of the arrhythmia" Int J Cardiol 108 326 331 10.1016/j.ijcard.2005.05.017 15985301 (Pubitemid 43348338)
46. P Korantzopoulos T Kolettis K Siogas J Goudevenos 2003 Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress Med Sci Monit 9 RA225 RA229 1:CAS:528:DC%2BD3sXps1amtr4%3D 12960937 (Pubitemid 37303894)
47. D Agostini I Carrio HJ Verberne 2009 How to use myocardial 123I-MIBG scintigraphy in chronic heart failure Eur J Nucl Med Mol Imaging 36 555 559 10.1007/s00259-008-0976-x 18989666
48. Y Inoue A Suzuki I Shirouzu T Machida Y Yoshizawa F Akita, et al. 2003 Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake J Nucl Cardiol 10 623 632 10.1016/S1071-3581(03)00652-4 14668774 (Pubitemid 38035397)
49. HJ Verberne C Feenstra WM de Jong GA Somsen BLF van Eck-Smit EB Busemann Sokole 2005 Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study Eur J Nucl Med Mol Imaging 32 1100 1107 10.1007/s00259-005-1810-3 15902438 (Pubitemid 41339287)